Biotricity is trading at $0.10, up 5.56%, without an identified company-specific catalyst.

  • No new company-specific announcement or major catalyst was identified for September 14, 2026.
  • Biotricity’s latest clearly indexed company release covers Q3 fiscal 2026 results, published February 11, 2026.
  • The broader market is lower, so today’s gain does not align with current index direction and remains unexplained.